Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application and kit of hsa-mir-134-3p as a molecular marker

A technology of molecular markers and kits, applied in the field of molecular biotechnology and its applications, to achieve the effects of reducing pain and risk, high reliability, and reducing altitude sickness

Active Publication Date: 2022-04-01
ARMY MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are few reports on the correlation between circulating microRNAs and AMS susceptibility.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application and kit of hsa-mir-134-3p as a molecular marker
  • Application and kit of hsa-mir-134-3p as a molecular marker
  • Application and kit of hsa-mir-134-3p as a molecular marker

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1 Correlation between the expression of microRNA in saliva samples and the risk of AMS

[0042] 1. Material and Specimen Collection Description

[0043] The saliva samples of AMS-susceptible persons were collected from AMS patients who entered the plateau rapidly before entering the plateau, a total of 75 cases. The saliva samples of normal people were collected from 49 cases of normal healthy people who entered the plateau rapidly before entering the plateau. The diagnosis of AMS was confirmed by the International Common Diagnostic Criteria-Lake Lewis Score. All the groups did not take any preventive medicine before taking saliva. A total of 10ml of saliva was collected from each sample in a sterile, enzyme-free 50ml centrifuge tube. The clinical case characteristics of the patients are shown in Table 1. This study has been approved by the Medical Ethics Committee of the Army Military Medical University (Third Military Medical University), and all specimens...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the application of hsa-miR-134-3p as a microRNA marker in the saliva of persons susceptible to acute altitude sickness screening, and the microRNA is used in the preparation of reagents or kits for screening persons susceptible to acute altitude sickness, saliva The expression of hsa-miR-134-3p in the specimen was down-regulated compared with the expression in the control. It also provides a kit for detecting the hsa-miR-134-3p molecule in the plain saliva of the tested human by the real-time fluorescent quantitative PCR method, and predicts the risk of acute altitude sickness through its expression level. As a molecular marker, the microRNA has the characteristics of strong specificity and high sensitivity, non-invasive and convenient acquisition of tested samples, and is suitable for large-scale screening of people susceptible to acute altitude sickness in the plains.

Description

technical field [0001] The invention belongs to the field of molecular biotechnology and its application. The invention relates to a microRNA molecular marker for screening the saliva of persons susceptible to acute altitude sickness, and further relates to its application and kit. Screen the risk of acute altitude sickness by screening the expression level of hsa-miR-134-3p in saliva, so as to evaluate the susceptibility of the human body to acute altitude sickness, and reduce the risk of acute altitude sickness in humans. Background technique [0002] Acute mountain sickness (AMS) occurs in plain people who have lived in low-altitude areas for a long time, 1-3 days after entering the plateau quickly without adapting to the new environment, including headache, dizziness, fatigue, insomnia , Emotional restlessness, flatulence, diarrhea and vomiting and a series of symptoms, among which severe headache is a typical symptom of AMS. In geography, a vast area with an altitude h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6883
Inventor 高钰琪鄂国基黄河张刚张二龙陈建徐刚孙滨达董华平柯贤峰何姝
Owner ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com